Lv0
0 积分 2024-03-29 加入
Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining In Vitro Experiments with Systems Modeling
1天前
已完结
Overcoming multidrug resistance using small molecule dynamic inhibitors by hijacking nascent and inducing turnover of mature ABCG2 for degradation in lysosomes
1个月前
已完结
ABCG2: determining its relevance in clinical drug resistance
1个月前
已完结
CD2 and TCR synergize for the activation of phospholipase C 1/calcium pathway at the immunological synapse
1个月前
已完结
New guise ADCs couple antibodies to degraders
1个月前
已完结
PD1 × VEGF blocking bispecifics for cancer draw big backing
1个月前
已完结
Rational engineering of degradation tail-driven CELMoD–antibody conjugates for precision malignancy therapy
1个月前
已完结
Degrader-antibody conjugates
1个月前
已完结
Epitope Mapping of Therapeutic Antibodies Targeting Human LAG3
3个月前
已完结
Asymmetrical Expression of PD1 and CD25 in T-cells Post-Initial Activation
3个月前
已完结
皖公网安备34019202002308
